Document ID: chunk:federal_register_of_legislation:F2017L00469:reg:9:p2
Version: federal_register_of_legislation:F2017L00469
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 5855–8451

the clinical worsening of bronchiectasis;
(16)      having pertussis of sufficient severity to require hospitalisation, within the five years before the clinical worsening of bronchiectasis;
(17)      having pulmonary tuberculosis or non-tuberculous mycobacterial infection of the lung before the clinical worsening of bronchiectasis;
(18)      having sarcoidosis of the lung before the clinical worsening of bronchiectasis;
(19)      having bronchial obstruction before the clinical worsening of bronchiectasis, where the bronchiectasis is distal to that obstruction;
Note: bronchial obstruction is defined in the Schedule 1 - Dictionary.
(20)      inhaling vapours, gases or fumes of a chemical agent from the specified list of chemical agents:
(a)          resulting in signs and symptoms of severe acute lower respiratory damage requiring medical attention within 48 hours after exposure; and
(b)          the persistence of respiratory symptoms and signs for at least one week after exposure,

         within the two years before the clinical worsening of bronchiectasis;

Note: specified list of chemical agents is defined in the Schedule 1 - Dictionary.
(21)      having aspiration pneumonitis within the two years before the clinical worsening of bronchiectasis;
Note: aspiration pneumonitis is defined in the Schedule 1 - Dictionary.
(22)      having gastro-oesophageal reflux disease, with erosive oesophagitis or oesophageal stricture, at the time of the clinical worsening of bronchiectasis;
(23)      having allergic bronchopulmonary aspergillosis at the time of the clinical worsening of bronchiectasis;
Note: allergic bronchopulmonary aspergillosis is defined in the Schedule 1 - Dictionary.
(24)      undergoing solid organ or bone marrow transplantation before the clinical worsening of bronchiectasis;
(25)      having fibrosis or fibrosing interstitial lung disease, involving the segment of the lung affected by bronchiectasis, before the clinical worsening of bronchiectasis;
(26)      being exposed to arsenic as specified before the clinical worsening of bronchiectasis;
Note: being exposed to arsenic as specified is defined in the Schedule 1 - Dictionary.
(27)      having a disease from the specified list of connective tissue diseases at the time of the clinical worsening of bronchiectasis;
Note: specified list of connective tissue diseases is defined in the Schedule 1 - Dictionary.
(28)      having inflammatory bowel disease at the time of the clinical worsening of bronchiectasis;
(29)      inability to obtain appropriate clinical management for bronchiectasis.